TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Orion Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
917,048
|
832,131
|
808,378 |
| Financial expenses |
9
|
2
|
15 |
| Earnings before taxes |
39,700
|
35,042
|
22,552 |
| EBITDA |
38,090
|
34,680
|
22,872 |
| Total assets |
214,920
|
282,286
|
236,756 |
| Current assets |
211,590
|
278,729
|
233,043 |
| Current liabilities |
40,304
|
123,410
|
93,061 |
| Equity capital |
171,526
|
155,860
|
140,793 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
49
|
48
|
48 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
79.8%
|
55.2%
|
59.5% |
| Turnover per employee |
18,715
|
17,336
|
16,841 |
| Profit as a percentage of turnover |
4.3%
|
4.2%
|
2.8% |
| Return on assets (ROA) |
18.5%
|
12.4%
|
9.5% |
| Current ratio |
525.0%
|
225.9%
|
250.4% |
| Return on equity (ROE) |
23.1%
|
22.5%
|
16.0% |
| Change turnover |
84,917
|
23,753
|
-374 |
| Change turnover % |
10%
|
3%
|
0% |
| Chg. No. of employees |
1
|
0
|
-5 |
| Chg. No. of employees % |
2%
|
0%
|
-9% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.